Head and Neck-Journal for the Sciences and Specialties of the Head and Neck, ISSN 1043-3074, 2014, Volume 36, Issue 3, pp. 444 - 455
The current management of minor salivary gland cancer is reviewed. These malignancies often present as a submucosal swelling and have been reported at all...
minor salivary gland | salivary gland neoplasms | carcinoma | management | outcome | SURGERY | ACINIC CELL CARCINOMAS | CONTRAST-ENHANCED MRI | MALIGNANT-TUMORS | PROGNOSTIC-FACTORS | OTORHINOLARYNGOLOGY | NUCLEOLAR ORGANIZER REGIONS | PHASE-II | ADENOID CYSTIC CARCINOMA | POSTOPERATIVE RADIATION-THERAPY | MUCOEPIDERMOID CARCINOMA | LOW-GRADE ADENOCARCINOMA | Laryngeal Neoplasms - radiotherapy | Oropharyngeal Neoplasms - diagnosis | Laryngeal Neoplasms - surgery | Prognosis | Humans | Oropharyngeal Neoplasms - radiotherapy | Salivary Glands, Minor | Oropharyngeal Neoplasms - pathology | Salivary Gland Neoplasms - diagnosis | Laryngeal Neoplasms - pathology | Biopsy, Fine-Needle | Diagnostic Imaging | Oropharyngeal Neoplasms - surgery | Biomarkers, Tumor - metabolism | Salivary Gland Neoplasms - radiotherapy | Salivary Gland Neoplasms - pathology | Laryngeal Neoplasms - diagnosis | Salivary Gland Neoplasms - surgery | Cancer
minor salivary gland | salivary gland neoplasms | carcinoma | management | outcome | SURGERY | ACINIC CELL CARCINOMAS | CONTRAST-ENHANCED MRI | MALIGNANT-TUMORS | PROGNOSTIC-FACTORS | OTORHINOLARYNGOLOGY | NUCLEOLAR ORGANIZER REGIONS | PHASE-II | ADENOID CYSTIC CARCINOMA | POSTOPERATIVE RADIATION-THERAPY | MUCOEPIDERMOID CARCINOMA | LOW-GRADE ADENOCARCINOMA | Laryngeal Neoplasms - radiotherapy | Oropharyngeal Neoplasms - diagnosis | Laryngeal Neoplasms - surgery | Prognosis | Humans | Oropharyngeal Neoplasms - radiotherapy | Salivary Glands, Minor | Oropharyngeal Neoplasms - pathology | Salivary Gland Neoplasms - diagnosis | Laryngeal Neoplasms - pathology | Biopsy, Fine-Needle | Diagnostic Imaging | Oropharyngeal Neoplasms - surgery | Biomarkers, Tumor - metabolism | Salivary Gland Neoplasms - radiotherapy | Salivary Gland Neoplasms - pathology | Laryngeal Neoplasms - diagnosis | Salivary Gland Neoplasms - surgery | Cancer
Journal Article
Pathology & Oncology Research, ISSN 1219-4956, 4/2019, Volume 25, Issue 2, pp. 585 - 591
Engulfment and cell motility 3 protein (ELMO3) is a protein that is involved in cell migration and promotes the remodeling of the cytoskeleton. Moreover, it is...
Biomedicine, general | Immunohistochemistry | Pathology | Biomedicine | Immunology | Minor salivary gland cancer | Molecular prognostic marker | Cancer Research | Oncology | ELMO3 | PREDICTS | ONCOLOGY | PATHOLOGY | CANCER | TUMORS | Salivary Gland Neoplasms - mortality | Prognosis | Biomarkers, Tumor - analysis | Humans | Middle Aged | Kaplan-Meier Estimate | Carcinoma - mortality | Male | Disease-Free Survival | Salivary Glands, Minor - pathology | Salivary Gland Neoplasms - metabolism | Aged, 80 and over | Adult | Female | Adaptor Proteins, Signal Transducing - biosynthesis | Aged | Carcinoma - metabolism | Carcinoma - pathology | Cytoskeletal Proteins - biosynthesis | Salivary Gland Neoplasms - pathology | Medical colleges | Carcinoma | Analysis | Oncology, Experimental | Research | Cancer | Proteins | Statistical analysis | Salivary glands | Staining | Salivary gland | Cytoskeleton | Patients | Cell migration | Cell adhesion & migration | Original
Biomedicine, general | Immunohistochemistry | Pathology | Biomedicine | Immunology | Minor salivary gland cancer | Molecular prognostic marker | Cancer Research | Oncology | ELMO3 | PREDICTS | ONCOLOGY | PATHOLOGY | CANCER | TUMORS | Salivary Gland Neoplasms - mortality | Prognosis | Biomarkers, Tumor - analysis | Humans | Middle Aged | Kaplan-Meier Estimate | Carcinoma - mortality | Male | Disease-Free Survival | Salivary Glands, Minor - pathology | Salivary Gland Neoplasms - metabolism | Aged, 80 and over | Adult | Female | Adaptor Proteins, Signal Transducing - biosynthesis | Aged | Carcinoma - metabolism | Carcinoma - pathology | Cytoskeletal Proteins - biosynthesis | Salivary Gland Neoplasms - pathology | Medical colleges | Carcinoma | Analysis | Oncology, Experimental | Research | Cancer | Proteins | Statistical analysis | Salivary glands | Staining | Salivary gland | Cytoskeleton | Patients | Cell migration | Cell adhesion & migration | Original
Journal Article
Otolaryngology–Head and Neck Surgery, ISSN 0194-5998, 2/2018, Volume 158, Issue 2, pp. 287 - 294
Objective We sought to describe the patient, tumor, and survival characteristics of minor salivary gland carcinoma (MSGC) of the oropharynx using a large,...
SEER | minor salivary gland carcinoma | oropharynx | incidence | demographics | SURVIVAL | SURGERY | MALIGNANT-TUMORS | MANAGEMENT | STAGE | ORAL-CAVITY | CLASSIFICATION | CANCER | TONGUE | OTORHINOLARYNGOLOGY | SQUAMOUS-CELL CARCINOMA | RADIOTHERAPY
SEER | minor salivary gland carcinoma | oropharynx | incidence | demographics | SURVIVAL | SURGERY | MALIGNANT-TUMORS | MANAGEMENT | STAGE | ORAL-CAVITY | CLASSIFICATION | CANCER | TONGUE | OTORHINOLARYNGOLOGY | SQUAMOUS-CELL CARCINOMA | RADIOTHERAPY
Journal Article
The Laryngoscope, ISSN 0023-852X, 07/2009, Volume 119, Issue 7, pp. 1334 - 1338
Objectives/Hypothesis: To analyze the outcomes of patients treated for minor salivary gland carcinoma with radiotherapy (RT), either alone or combined with...
radiotherapy | Minor salivary gland carcinoma | surgery | Radiotherapy | Surgery | MEDICINE, RESEARCH & EXPERIMENTAL | IRRADIATION | HEAD | MALIGNANT-TUMORS | MANAGEMENT | OTORHINOLARYNGOLOGY | NECK | Humans | Middle Aged | Male | Survival Rate | Treatment Outcome | Combined Modality Therapy | Adolescent | Aged, 80 and over | Salivary Gland Neoplasms - radiotherapy | Adult | Female | Aged | Retrospective Studies | Neoplasm Staging | Salivary Gland Neoplasms - pathology | Salivary Gland Neoplasms - surgery
radiotherapy | Minor salivary gland carcinoma | surgery | Radiotherapy | Surgery | MEDICINE, RESEARCH & EXPERIMENTAL | IRRADIATION | HEAD | MALIGNANT-TUMORS | MANAGEMENT | OTORHINOLARYNGOLOGY | NECK | Humans | Middle Aged | Male | Survival Rate | Treatment Outcome | Combined Modality Therapy | Adolescent | Aged, 80 and over | Salivary Gland Neoplasms - radiotherapy | Adult | Female | Aged | Retrospective Studies | Neoplasm Staging | Salivary Gland Neoplasms - pathology | Salivary Gland Neoplasms - surgery
Journal Article
Otolaryngology - Head and Neck Surgery, ISSN 0194-5998, 2010, Volume 143, Issue 1, pp. 122 - 126
To describe the epidemiology and comparative survival for minor salivary gland cancer of the oral cavity. Historical cohort study. Academic medical center....
SURGERY | EXPERIENCE | NEOPLASMS | TUMORS | OTORHINOLARYNGOLOGY | RADIATION-THERAPY | Salivary Gland Neoplasms - mortality | United States - epidemiology | SEER Program | Age Factors | Humans | Middle Aged | Carcinoma - mortality | Male | Salivary Glands, Minor | Survival Rate | Sex Factors | Female | Retrospective Studies | Carcinoma - pathology | Neoplasm Staging | Salivary Gland Neoplasms - pathology | Cohort Studies
SURGERY | EXPERIENCE | NEOPLASMS | TUMORS | OTORHINOLARYNGOLOGY | RADIATION-THERAPY | Salivary Gland Neoplasms - mortality | United States - epidemiology | SEER Program | Age Factors | Humans | Middle Aged | Carcinoma - mortality | Male | Salivary Glands, Minor | Survival Rate | Sex Factors | Female | Retrospective Studies | Carcinoma - pathology | Neoplasm Staging | Salivary Gland Neoplasms - pathology | Cohort Studies
Journal Article
European Archives of Oto-Rhino-Laryngology, ISSN 0937-4477, 9/2016, Volume 273, Issue 9, pp. 2717 - 2726
Minor salivary gland carcinomas represent a heterogeneous group of tumors with broad variation in clinical appearance and histopathology. Clinical data of...
Cyclooxygenase | Medicine & Public Health | Targeted anticancer therapy | Small salivary gland tumors | Head and Neck Surgery | Otorhinolaryngology | Neurosurgery | Anti-Wnt-1 antibodies | SURVIVAL | HEAD | PROTEIN | CYCLOOXYGENASE-1 | CANCER | CHEMOTHERAPY | OTORHINOLARYNGOLOGY | MALIGNANCIES | EXPRESSION | Salivary Gland Neoplasms - mortality | Glutathione S-Transferase pi - metabolism | Humans | Middle Aged | Carcinoma - mortality | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Male | Salivary Glands, Minor | Smoothened Receptor - metabolism | beta Catenin - metabolism | Disease-Free Survival | Salivary Gland Neoplasms - metabolism | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Carcinoma - metabolism | Carcinoma - pathology | Salivary Gland Neoplasms - pathology | Proteins | Viral antibodies | COX-2 inhibitors | Medical colleges | Glutathione transferase | Antibodies | Health aspects | Histochemistry | Cancer | Index Medicus
Cyclooxygenase | Medicine & Public Health | Targeted anticancer therapy | Small salivary gland tumors | Head and Neck Surgery | Otorhinolaryngology | Neurosurgery | Anti-Wnt-1 antibodies | SURVIVAL | HEAD | PROTEIN | CYCLOOXYGENASE-1 | CANCER | CHEMOTHERAPY | OTORHINOLARYNGOLOGY | MALIGNANCIES | EXPRESSION | Salivary Gland Neoplasms - mortality | Glutathione S-Transferase pi - metabolism | Humans | Middle Aged | Carcinoma - mortality | Vascular Endothelial Growth Factor Receptor-2 - metabolism | Male | Salivary Glands, Minor | Smoothened Receptor - metabolism | beta Catenin - metabolism | Disease-Free Survival | Salivary Gland Neoplasms - metabolism | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Carcinoma - metabolism | Carcinoma - pathology | Salivary Gland Neoplasms - pathology | Proteins | Viral antibodies | COX-2 inhibitors | Medical colleges | Glutathione transferase | Antibodies | Health aspects | Histochemistry | Cancer | Index Medicus
Journal Article
Journal of Oral and Maxillofacial Surgery, ISSN 0278-2391, 2014, Volume 72, Issue 1, pp. 205 - 210
Purpose Surgical resection and subsequent neck dissection (ND) in cases of clinically positive lymph nodes is an accepted primary treatment strategy for...
Surgery | MANAGEMENT | DENTISTRY, ORAL SURGERY & MEDICINE | DENMARK 1990-2005 | DANISH HEAD | PRIMARY PAROTID CARCINOMA | MUCOEPIDERMOID CARCINOMA | TUMORS | CANCER GROUP DAHANCA | CHEMOTHERAPY | Lymphatic Metastasis - diagnosis | Lymph Nodes - pathology | Follow-Up Studies | Humans | Middle Aged | Tomography, X-Ray Computed - methods | Male | Young Adult | Submandibular Gland Neoplasms - surgery | Neoplasm Grading | Salivary Glands, Minor - surgery | Aged, 80 and over | Adult | Carcinoma, Adenoid Cystic - secondary | Female | Parotid Neoplasms - surgery | Elective Surgical Procedures - methods | Retrospective Studies | Carcinoma - pathology | Radiotherapy, Adjuvant | Child | Carcinoma - secondary | Carcinoma, Adenoid Cystic - surgery | Carcinoma, Mucoepidermoid - secondary | Carcinoma - surgery | Carcinoma, Mucoepidermoid - surgery | Neck Dissection - methods | Adenocarcinoma - secondary | Adolescent | Aged | Neoplasm Staging | Adenocarcinoma - surgery | Cohort Studies | Salivary Gland Neoplasms - surgery | Sects | College teachers | Cancer | Medical informatics
Surgery | MANAGEMENT | DENTISTRY, ORAL SURGERY & MEDICINE | DENMARK 1990-2005 | DANISH HEAD | PRIMARY PAROTID CARCINOMA | MUCOEPIDERMOID CARCINOMA | TUMORS | CANCER GROUP DAHANCA | CHEMOTHERAPY | Lymphatic Metastasis - diagnosis | Lymph Nodes - pathology | Follow-Up Studies | Humans | Middle Aged | Tomography, X-Ray Computed - methods | Male | Young Adult | Submandibular Gland Neoplasms - surgery | Neoplasm Grading | Salivary Glands, Minor - surgery | Aged, 80 and over | Adult | Carcinoma, Adenoid Cystic - secondary | Female | Parotid Neoplasms - surgery | Elective Surgical Procedures - methods | Retrospective Studies | Carcinoma - pathology | Radiotherapy, Adjuvant | Child | Carcinoma - secondary | Carcinoma, Adenoid Cystic - surgery | Carcinoma, Mucoepidermoid - secondary | Carcinoma - surgery | Carcinoma, Mucoepidermoid - surgery | Neck Dissection - methods | Adenocarcinoma - secondary | Adolescent | Aged | Neoplasm Staging | Adenocarcinoma - surgery | Cohort Studies | Salivary Gland Neoplasms - surgery | Sects | College teachers | Cancer | Medical informatics
Journal Article
Head & Neck, ISSN 1043-3074, 10/2011, Volume 33, Issue 10, pp. 1406 - 1412
Background This study was performed to define prognostic factors and management of minor salivary gland carcinoma of the oral cavity and oropharynx . Methods...
minor salivary gland carcinoma | oral cavity salivary gland carcinoma | oropharynx salivary gland carcinoma | SURGERY | SURVIVAL | MALIGNANT-TUMORS | NEOPLASMS | OTORHINOLARYNGOLOGY | POSTOPERATIVE RADIOTHERAPY | ADENOID CYSTIC CARCINOMA | MUCOEPIDERMOID CARCINOMA | RADIATION-THERAPY | Oropharyngeal Neoplasms - therapy | Multivariate Analysis | Salivary Gland Neoplasms - mortality | Lymph Nodes - pathology | Prognosis | Humans | Middle Aged | Oropharyngeal Neoplasms - mortality | Carcinoma - mortality | Male | Oropharyngeal Neoplasms - pathology | Young Adult | Neoplasm Grading | Salivary Glands, Minor - surgery | Aged, 80 and over | Adult | Female | Retrospective Studies | Carcinoma - pathology | Radiotherapy, Adjuvant | Lymphatic Metastasis | Mouth Neoplasms - mortality | Mouth Neoplasms - therapy | Disease-Free Survival | Salivary Glands, Minor - pathology | Salivary Gland Neoplasms - therapy | Adolescent | Mouth Neoplasms - pathology | Carcinoma - therapy | Aged | Salivary Gland Neoplasms - pathology
minor salivary gland carcinoma | oral cavity salivary gland carcinoma | oropharynx salivary gland carcinoma | SURGERY | SURVIVAL | MALIGNANT-TUMORS | NEOPLASMS | OTORHINOLARYNGOLOGY | POSTOPERATIVE RADIOTHERAPY | ADENOID CYSTIC CARCINOMA | MUCOEPIDERMOID CARCINOMA | RADIATION-THERAPY | Oropharyngeal Neoplasms - therapy | Multivariate Analysis | Salivary Gland Neoplasms - mortality | Lymph Nodes - pathology | Prognosis | Humans | Middle Aged | Oropharyngeal Neoplasms - mortality | Carcinoma - mortality | Male | Oropharyngeal Neoplasms - pathology | Young Adult | Neoplasm Grading | Salivary Glands, Minor - surgery | Aged, 80 and over | Adult | Female | Retrospective Studies | Carcinoma - pathology | Radiotherapy, Adjuvant | Lymphatic Metastasis | Mouth Neoplasms - mortality | Mouth Neoplasms - therapy | Disease-Free Survival | Salivary Glands, Minor - pathology | Salivary Gland Neoplasms - therapy | Adolescent | Mouth Neoplasms - pathology | Carcinoma - therapy | Aged | Salivary Gland Neoplasms - pathology
Journal Article
Oral Oncology, ISSN 1368-8375, 2011, Volume 48, Issue 5, pp. 456 - 462
Summary Minor salivary gland carcinoma of the hard palate is rare, and its long-term survival rate is high, making it difficult to evaluate the prognostic...
Otolaryngology | Hematology, Oncology and Palliative Medicine | Hard palate | Minor salivary gland carcinoma | Prognosis | Radiotherapy | Surgery | POPULATION | ONCOLOGY | DENTISTRY, ORAL SURGERY & MEDICINE | EXPERIENCE | TUMORS | Carcinoma, Adenoid Cystic - therapy | Salivary Gland Neoplasms - mortality | Follow-Up Studies | Mixed Tumor, Malignant - mortality | Humans | Middle Aged | Palate, Hard - surgery | Male | Young Adult | Salivary Glands, Minor - surgery | Carcinoma, Mucoepidermoid - therapy | Palatal Neoplasms - mortality | Aged, 80 and over | Adult | Female | Retrospective Studies | Neck | Mixed Tumor, Malignant - therapy | Palatal Neoplasms - therapy | Salivary Glands, Minor - diagnostic imaging | Survival Rate | Treatment Outcome | Lymphatic Metastasis | Lymph Nodes | Radiography | Disease-Free Survival | Carcinoma, Acinar Cell - mortality | Carcinoma, Adenoid Cystic - mortality | Palate, Hard - diagnostic imaging | Salivary Gland Neoplasms - therapy | Adolescent | Aged | Carcinoma, Mucoepidermoid - mortality | Carcinoma, Acinar Cell - therapy | Care and treatment | Carcinoma | Patient outcomes | Cancer
Otolaryngology | Hematology, Oncology and Palliative Medicine | Hard palate | Minor salivary gland carcinoma | Prognosis | Radiotherapy | Surgery | POPULATION | ONCOLOGY | DENTISTRY, ORAL SURGERY & MEDICINE | EXPERIENCE | TUMORS | Carcinoma, Adenoid Cystic - therapy | Salivary Gland Neoplasms - mortality | Follow-Up Studies | Mixed Tumor, Malignant - mortality | Humans | Middle Aged | Palate, Hard - surgery | Male | Young Adult | Salivary Glands, Minor - surgery | Carcinoma, Mucoepidermoid - therapy | Palatal Neoplasms - mortality | Aged, 80 and over | Adult | Female | Retrospective Studies | Neck | Mixed Tumor, Malignant - therapy | Palatal Neoplasms - therapy | Salivary Glands, Minor - diagnostic imaging | Survival Rate | Treatment Outcome | Lymphatic Metastasis | Lymph Nodes | Radiography | Disease-Free Survival | Carcinoma, Acinar Cell - mortality | Carcinoma, Adenoid Cystic - mortality | Palate, Hard - diagnostic imaging | Salivary Gland Neoplasms - therapy | Adolescent | Aged | Carcinoma, Mucoepidermoid - mortality | Carcinoma, Acinar Cell - therapy | Care and treatment | Carcinoma | Patient outcomes | Cancer
Journal Article
European Archives of Oto-Rhino-Laryngology, ISSN 0937-4477, 05/2016, Volume 273, Issue 5, pp. 1283 - 1292
Minor salivary gland carcinoma is a rare and heterogeneous type of cancer. Molecular prognostic and predictive markers are sparse. The aim of this study was to...
PIN1 | β-Catenin | Cyclin D1 | Minor salivary gland cancer | Molecular prognostic markers | HEAD | E-CADHERIN | MUCOEPIDERMOID CARCINOMA | TUMORS | BREAST-CANCER | OVEREXPRESSION | APC | OTORHINOLARYNGOLOGY | beta-Catenin | SQUAMOUS-CELL CARCINOMA | ADENOID CYSTIC CARCINOMA | EXPRESSION | Cyclin D1 - metabolism | NIMA-Interacting Peptidylprolyl Isomerase - metabolism | Predictive Value of Tests | Prognosis | Carcinoma, Adenoid Cystic - pathology | Outcome Assessment (Health Care) | Carcinoma, Adenoid Cystic - metabolism | Humans | Middle Aged | Male | Statistics as Topic | beta Catenin - metabolism | Austria | Salivary Glands, Minor - pathology | Salivary Gland Neoplasms - metabolism | Survival Analysis | Biomarkers, Tumor - metabolism | Female | Retrospective Studies | Salivary Gland Neoplasms - pathology
PIN1 | β-Catenin | Cyclin D1 | Minor salivary gland cancer | Molecular prognostic markers | HEAD | E-CADHERIN | MUCOEPIDERMOID CARCINOMA | TUMORS | BREAST-CANCER | OVEREXPRESSION | APC | OTORHINOLARYNGOLOGY | beta-Catenin | SQUAMOUS-CELL CARCINOMA | ADENOID CYSTIC CARCINOMA | EXPRESSION | Cyclin D1 - metabolism | NIMA-Interacting Peptidylprolyl Isomerase - metabolism | Predictive Value of Tests | Prognosis | Carcinoma, Adenoid Cystic - pathology | Outcome Assessment (Health Care) | Carcinoma, Adenoid Cystic - metabolism | Humans | Middle Aged | Male | Statistics as Topic | beta Catenin - metabolism | Austria | Salivary Glands, Minor - pathology | Salivary Gland Neoplasms - metabolism | Survival Analysis | Biomarkers, Tumor - metabolism | Female | Retrospective Studies | Salivary Gland Neoplasms - pathology
Journal Article
ORL, ISSN 0301-1569, 11/2014, Volume 76, Issue 4, pp. 222 - 226
Aims: To explore the clinical characteristics and treatment of malignant minor salivary gland carcinomas of the larynx. Methods: Clinical patient information...
Original Paper | Clinical protocols | Histopathology | Laryngeal neoplasms | Salivary gland carcinoma | OTORHINOLARYNGOLOGY | ADENOID CYSTIC CARCINOMA | RADIOTHERAPY | MUCOEPIDERMOID CARCINOMA | Prognosis | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Carcinoma, Squamous Cell - therapy | Male | Laryngeal Neoplasms - pathology | Laryngeal Neoplasms - therapy | Salivary Glands, Minor - pathology | Salivary Gland Neoplasms - therapy | Survival Analysis | Aged, 80 and over | Adult | Female | Aged | Salivary Gland Neoplasms - pathology | Body fluids | Larynx | Cancer
Original Paper | Clinical protocols | Histopathology | Laryngeal neoplasms | Salivary gland carcinoma | OTORHINOLARYNGOLOGY | ADENOID CYSTIC CARCINOMA | RADIOTHERAPY | MUCOEPIDERMOID CARCINOMA | Prognosis | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Carcinoma, Squamous Cell - therapy | Male | Laryngeal Neoplasms - pathology | Laryngeal Neoplasms - therapy | Salivary Glands, Minor - pathology | Salivary Gland Neoplasms - therapy | Survival Analysis | Aged, 80 and over | Adult | Female | Aged | Salivary Gland Neoplasms - pathology | Body fluids | Larynx | Cancer
Journal Article
Cancer Management and Research, ISSN 1179-1322, 2018, Volume 10, pp. 2163 - 2172
Purpose: The prognostic value of primary tumor surgery (PTS) in minor salivary-gland carcinoma (MiSGC) with distant metastasis (DM) at diagnosis has never been...
Distant metastasis | Minor salivary gland carcinoma | Primary tumor surgery | SEER | T stage | Primary site | TREND-ANALYSIS | POPULATION | HEAD | MALIGNANT-TUMORS | MANAGEMENT | minor salivary gland carcinoma | IMPROVED SURVIVAL | primary tumor surgery | RADIATION-THERAPY | ONCOLOGY | COLORECTAL-CANCER | MODEL SELECTION | primary site | NECK | distant metastasis | Cancer patients | Diagnosis | Salivary gland tumors | Health aspects | Chemotherapy | Sinuses | Medical prognosis | Surgery | Mortality | Population | Larynx | Metastasis | Stomach cancer | Cancer therapies | Data bases | Tumors
Distant metastasis | Minor salivary gland carcinoma | Primary tumor surgery | SEER | T stage | Primary site | TREND-ANALYSIS | POPULATION | HEAD | MALIGNANT-TUMORS | MANAGEMENT | minor salivary gland carcinoma | IMPROVED SURVIVAL | primary tumor surgery | RADIATION-THERAPY | ONCOLOGY | COLORECTAL-CANCER | MODEL SELECTION | primary site | NECK | distant metastasis | Cancer patients | Diagnosis | Salivary gland tumors | Health aspects | Chemotherapy | Sinuses | Medical prognosis | Surgery | Mortality | Population | Larynx | Metastasis | Stomach cancer | Cancer therapies | Data bases | Tumors
Journal Article
The Laryngoscope, ISSN 0023-852X, 11/2013, Volume 123, Issue 11, pp. 2675 - 2680
Objectives/Hypothesis Postoperative radiation therapy is often used in patients with high‐risk salivary gland carcinomas. In this study we evaluated the...
postoperative | toxicity | radiotherapy | head and neck | Minor salivary gland | SURVIVAL | MEDICINE, RESEARCH & EXPERIMENTAL | HEAD | MALIGNANT-TUMORS | MANAGEMENT | POSTOPERATIVE RADIOTHERAPY | PATTERNS | IRRADIATION | OTORHINOLARYNGOLOGY | ADENOID CYSTIC CARCINOMA | NECK | Salivary Gland Neoplasms - mortality | Prognosis | Humans | Middle Aged | Male | Salivary Glands, Minor | Survival Rate | Treatment Outcome | Combined Modality Therapy | Radiography | Young Adult | Salivary Gland Neoplasms - diagnostic imaging | Time Factors | Adolescent | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Cohort Studies | Salivary Gland Neoplasms - surgery | Care and treatment | Nuclear radiation | Analysis | Adjuvant treatment | Radiotherapy | Health aspects | Cancer | Index Medicus
postoperative | toxicity | radiotherapy | head and neck | Minor salivary gland | SURVIVAL | MEDICINE, RESEARCH & EXPERIMENTAL | HEAD | MALIGNANT-TUMORS | MANAGEMENT | POSTOPERATIVE RADIOTHERAPY | PATTERNS | IRRADIATION | OTORHINOLARYNGOLOGY | ADENOID CYSTIC CARCINOMA | NECK | Salivary Gland Neoplasms - mortality | Prognosis | Humans | Middle Aged | Male | Salivary Glands, Minor | Survival Rate | Treatment Outcome | Combined Modality Therapy | Radiography | Young Adult | Salivary Gland Neoplasms - diagnostic imaging | Time Factors | Adolescent | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Cohort Studies | Salivary Gland Neoplasms - surgery | Care and treatment | Nuclear radiation | Analysis | Adjuvant treatment | Radiotherapy | Health aspects | Cancer | Index Medicus
Journal Article
Head & Neck, ISSN 1043-3074, 03/2017, Volume 39, Issue 3, pp. 572 - 577
Background The purpose of this study was to present our preliminary exploration of safety and efficacy of postoperative low‐dose‐rate brachytherapy for the...
minor salivary gland | lip | brachytherapy | buccal | carcinoma | SURGERY | HEAD | MANAGEMENT | NEOPLASMS | TUMORS | CANCER | RADIATION-THERAPY | RECURRENT | OTORHINOLARYNGOLOGY | ADENOID CYSTIC CARCINOMA | Immunohistochemistry | Salivary Gland Neoplasms - mortality | Prognosis | Humans | Middle Aged | Male | Iodine Radioisotopes - therapeutic use | Salivary Glands, Minor - surgery | Adult | Female | Mouth Neoplasms - radiotherapy | Lip Neoplasms - radiotherapy | Retrospective Studies | Radiotherapy, Adjuvant | Salivary Glands, Minor - radiation effects | Lip Neoplasms - pathology | Lip Neoplasms - surgery | Brachytherapy - methods | Kaplan-Meier Estimate | Treatment Outcome | Mouth Neoplasms - mortality | Disease-Free Survival | Salivary Glands, Minor - pathology | Mouth Neoplasms - surgery | Survival Analysis | Mouth Neoplasms - pathology | Salivary Gland Neoplasms - radiotherapy | Aged | Biopsy, Needle | Salivary Gland Neoplasms - pathology | Cohort Studies | Lip Neoplasms - mortality | Salivary Gland Neoplasms - surgery | Radioisotope brachytherapy | Cancer | Index Medicus
minor salivary gland | lip | brachytherapy | buccal | carcinoma | SURGERY | HEAD | MANAGEMENT | NEOPLASMS | TUMORS | CANCER | RADIATION-THERAPY | RECURRENT | OTORHINOLARYNGOLOGY | ADENOID CYSTIC CARCINOMA | Immunohistochemistry | Salivary Gland Neoplasms - mortality | Prognosis | Humans | Middle Aged | Male | Iodine Radioisotopes - therapeutic use | Salivary Glands, Minor - surgery | Adult | Female | Mouth Neoplasms - radiotherapy | Lip Neoplasms - radiotherapy | Retrospective Studies | Radiotherapy, Adjuvant | Salivary Glands, Minor - radiation effects | Lip Neoplasms - pathology | Lip Neoplasms - surgery | Brachytherapy - methods | Kaplan-Meier Estimate | Treatment Outcome | Mouth Neoplasms - mortality | Disease-Free Survival | Salivary Glands, Minor - pathology | Mouth Neoplasms - surgery | Survival Analysis | Mouth Neoplasms - pathology | Salivary Gland Neoplasms - radiotherapy | Aged | Biopsy, Needle | Salivary Gland Neoplasms - pathology | Cohort Studies | Lip Neoplasms - mortality | Salivary Gland Neoplasms - surgery | Radioisotope brachytherapy | Cancer | Index Medicus
Journal Article
Journal of Oral Pathology & Medicine, ISSN 0904-2512, 09/2012, Volume 41, Issue 8, pp. 598 - 602
J Oral Pathol Med (2012) 41: 598–602 Background: Salivary gland carcinomas are a heterogeneous group of tumors with varying malignant potential. In this...
Ki‐67 | prognostic factors | immunohistochemistry | salivary gland carcinoma | Immunohistochemistry | Ki-67 | Prognostic factors | Salivary gland carcinoma | PARAFFIN SECTIONS | HEAD | POPULATION | ACINIC CELL CARCINOMAS | MIB-1 ANTIBODY | PROLIFERATION | PATHOLOGY | TUMORS | CANCER | DENTISTRY, ORAL SURGERY & MEDICINE | ADENOID CYSTIC CARCINOMA | BCL-2 EXPRESSION | Adenocarcinoma - pathology | Prognosis | Age Factors | Follow-Up Studies | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Male | Young Adult | Neoplasm Grading | Aged, 80 and over | Adult | Female | Carcinoma - pathology | Child | Submandibular Gland Neoplasms - pathology | Carcinoma, Adenoid Cystic - pathology | Biomarkers, Tumor - analysis | Survival Rate | Treatment Outcome | Disease-Free Survival | Ki-67 Antigen - analysis
Ki‐67 | prognostic factors | immunohistochemistry | salivary gland carcinoma | Immunohistochemistry | Ki-67 | Prognostic factors | Salivary gland carcinoma | PARAFFIN SECTIONS | HEAD | POPULATION | ACINIC CELL CARCINOMAS | MIB-1 ANTIBODY | PROLIFERATION | PATHOLOGY | TUMORS | CANCER | DENTISTRY, ORAL SURGERY & MEDICINE | ADENOID CYSTIC CARCINOMA | BCL-2 EXPRESSION | Adenocarcinoma - pathology | Prognosis | Age Factors | Follow-Up Studies | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Male | Young Adult | Neoplasm Grading | Aged, 80 and over | Adult | Female | Carcinoma - pathology | Child | Submandibular Gland Neoplasms - pathology | Carcinoma, Adenoid Cystic - pathology | Biomarkers, Tumor - analysis | Survival Rate | Treatment Outcome | Disease-Free Survival | Ki-67 Antigen - analysis